SynGenSys
PrivateLast Round
Seed
Apr 1, 2025
Total Funding Raised
$4.09M
Momentum Score
25 /100
Company Overview
SynGenSys is a biotechnology company that designs synthetic gene promoter systems to address bottlenecks in biopharma manufacturing and enhance cell and gene therapy development.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynGenSys Comps
Public and private peers based on sector, stage, and business model.
SynGenSys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2025 | ||||
| Seed | Apr 3, 2024 |
SynGenSys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UKRI Innovate UK | Seed |
| Takeda Ventures | Seed |
| The University of Sheffield | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
$1.84M round with Takeda Ventures and UKRI
- Jun 21, 2024
Grew 40% QoQ, from 10 to 14 employees.
SynGenSys Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SynGenSys's valuation, stock price, and market status.
Firmographic Details
HeadquartersSheffield
Employee Range19
Year Founded2021
Last FundingApr 1, 2025
